spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Natoli Engineering Company Now Offers Plastic Media for Automated Polishing

Natoli Engineering Company, Inc.

Natoli Engineering Company, Inc. announces an addition to their Tablet Compression Accessories Catalog

ST. CHARLES, MO., U.S. (July 26, 2017) — Natoli Engineering Company, Inc. announces an addition to their Tablet Compression Accessories Catalog—PolyPlus® and PolyPlus Prime® plastic media for use with automated polishing systems.

Natoli strives to offer solutions to customer problems in every area of the tablet compression process. If you are using drag finishing (automated polishing), plastic media offers an alternative to traditional walnut shell based media.

Why Plastic?

"We're seeing a lot more interest in the plastic media, especially from pharmaceutical companies," says Cory Terry, Natoli's Parts and Accessories Catalog Manager. "With rising concerns over allergens, plastic media is the ideal solution for an alternative to traditional walnut shell media." Additionally, when compared to walnut shell media, plastic media creates minimal dust during the polishing process, can be used many times over, and can even eliminate the need for a vacuum system.

Product Details

Both varieties of plastic media— PolyPlus® (Type II) and PolyPlus Prime®—are sized 40/60 mil spec and come in 50lb (22.68 kg) boxes. The plastic has been thoroughly tested for quality assurance, and Natoli offers Material Safety Data Sheets on both. The PolyPlus Prime® media is made from 100% “virgin” urea resin, and does not contain the residue-causing calcium carbonate typically found in other plastics, making it ideal for pharmaceutical use.

For more information on the plastic media or to get a quote, visit Natoli’s website at https://natoli.com/ or contact a Natoli Representative at: +1-636-926-8900.

About Natoli

Natoli is the innovative, global leader in tablet compression tooling manufacturing with a network of sales representatives worldwide. Family owned and headquartered in St. Charles, Missouri, USA, Natoli offers customers a multitude of products and services, including tablet compression tooling, production and R&D tablet presses, replacement parts for most major tablet press brands, tablet press accessories, tablet design software, technical training, metallurgy studies and more.

Natoli Engineering Company Media Contact:

Jennifer Garrett
Director of Marketing
26 Research Park Circle
St. Charles, MO. 63304
636-926-8900
catalog3@natoli.com
phone +1 636 926 8900
email info@natoli.com
web www.natoli.com
email 28 Research Park Circle, Saint Charles, MO 63304, US
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Time for a sterile discussion: What sterilisation option is right for your business?


More info >>


White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>

Industry Events

6th Annual Cancer Vaccines Conference

27-28 September 2017, Copthorne Tara Hotel, London UK

Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies. SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement